Superworth

Haemonetics EV/EBIT HAE

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Nov 2, 2026
27.1×
10-year median
31.2×
Against its 10-year history
26th
percentile: 0 is its lowest day, 100 its highest
10-year range
13.4× to 63.8×
Peer median
21.0×

Haemonetics' EV/EBIT is 27.1× as of Nov 2, 2026.

That is below its ten-year median of 31.2×, lower than on 74% of days in the last ten years.

Over that time it ranged from 13.4× in Mar 2026 to 63.8× in Sep 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 21.0×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far27.1×13.4×27.1×
202519.3×13.6×28.6×
202427.9×24.1×31.3×
202326.7×25.7×38.8×
202234.6×34.5×56.3×
202145.7×18.8×50.6×
202039.4×25.2×39.7×
201938.4×38.4×58.1×
201852.5×39.4×63.8×
201736.6×26.7×37.0×
201629.7×18.6×30.2×
201522.8×22.1×30.8×
201426.0×18.1×26.2×
201326.6×24.6×37.5×
201230.8×12.7×31.4×
201112.5×10.8×13.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.

CompanyEV/EBIT
HAEHaemonetics27.1×
MMSIMerit Medical Systems26.0×
VNTVontier11.5×
BMIBadger Meter26.9×
MSAMSA Safety18.4×
ICUIICU Medical44.9×
NVSTEnvista15.6×
ATRCAtriCure212×
WRBYWarby Parkern/m
PODDInsulet21.0×
GMEDGlobus Medical15.9×
Peer median21.0×

Where Haemonetics ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Haemonetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.